The present invention relates to fused pyrazole derivatives, and pharmaceutical compositions including the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.
本发明涉及融合的
吡唑衍
生物和包括它们的药物组合物,它们是一种或多种FGFR酶的
抑制剂,并且在治疗与FGFR相关的疾病,如癌症方面具有用处。